The National Cattlemen’s Beef Association (NCBA) hailed the reauthorization of the Animal Drug User Fee Act. The act allows the FDA’s Center for Veterinary Medicine to collect fees from animal health companies, which fund the agency’s review and approval process for new animal drugs. ADUFA ensures that FDA has an efficient system for authorizing new cattle medicines and diagnostic tools that keep livestock healthy and protect our safe, wholesome food supply.
“Keeping our livestock healthy is on every cattle producer’s mind,” says NCBA President Todd Wilkinson. “NCBA made this reauthorization a top priority at the 2023 Cattle Industry Convention, and I’m proud to see our team’s hard work pay off.”
NCBA Chief Veterinarian Kathy Simmons says drug innovations are happening every day. “This ensures that FDA has the resources it needs to review these new technologies for safety and efficacy and to bring them to market for cattle producers,” Simmons says.
(From the National Association of Farm Broadcasters)